Evolugate Takes Up the Challenge of Boosting Host Cells Used to Manufacture Covid-19 Vaccines

The Covid-19 epidemic has left the world devastated, with over 350,000 dead and the global economy in shambles in just 5 months. A vaccine for the virus that causes Covid-19, SARS-CoV-2, is desperately needed, yet vaccine development typically takes years from conception to deployment. Developing a safe and effective vaccine is an important first step, … Continue reading Evolugate Takes Up the Challenge of Boosting Host Cells Used to Manufacture Covid-19 Vaccines

HR Grant

July 2014 – Evolugate LLC is one of five Gainesville companies recently awarded funds through the Healthcare, Biomanufacturing, Occupational and Technology Training (HBOTT) program provided by CareerSource North Central Florida. Funded through an H1-B Technical Skills Training grant provided by the U.S. Department of Labor, Employment and Training Administration, HBOTT allows employers to hire, train … Continue reading HR Grant

Scientific Publication

January 2012, a team of scientists at Evolugate developed a thermophilic strain of E. coli K-12. Their results were reported in the peer reviewed scientific journal “Applied and Environmental Microbiology ” published by the American Society for Microbiology (ASM). Details

Research Grant

March 2011, Evolugate was awarded a phase 1 SBIR grant from the Army Research Laboratory to increase the maximal growth temperature of a strain of heterotrophic algae. Increasing the maximal growth temperature will reduce the ratio of unsaturated fatty acids in the algal oil, and make it more suitable for conversion to bio jet-fuel. Using … Continue reading Research Grant